HIV self-testing: an optimal approach for HIV diagnosis during COVID-19 pandemic

Résumé fourni par la source

Human immunodeficiency virus self-testing (HIVST) has gained popularity as a last-mile option for achieving UNAIDS 95-95-95 targets by 2030.HIV testing has been a serious concern since the start of COVID-19 pandemic, and enhanced measures were needed to improve access to promote testing.This study aimed to review the evidence related to HIVST program during COVID-19.In this narrative review, a literature search was performed in English databases, including Cochrane Library, PubMed, Scopus, and Science Direct as well as in Persian databases, such as Magiran and Scientific Information Database.In addition, World Health Organization, Joint United Nations Programme on HIV and AIDS, and reports of Centre for Disease Control and Prevention were explored.The search was conducted up to January 8, 2022.Kenya was the first country to publish a national HIVST policy in 2008.U.S. Food and Drug Administration licensed the first-ever fast HIV home test in July 2012.HIVST products can be delivered via various channels, including those financed by government or donor funds as well as private and public-private sectors collaborations.Service delivery models include facility-based directed, facility secondary distribution, community-based platforms, open-access platforms, virtual platforms, workplaces model, and integrated model.Given this new situation and COVID-19's effects on people, societies, and health services, governments must resolve political and regulatory obstacles to HIV testing and universal coverage.HIVST can help by using peer-, partner-, and community-based delivery methods as well as engagement of non-governmental and civil society organizations.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.